Publication date: Jun 28, 2024
Purpose: The present study aimed to uncover the impact of long COVID on the working situations of Japanese patients. Methods: Changes in the working situations of the patients who visited our long COVID clinic were evaluated from medical records for the aspects of physical status, quality of life (QOL), and mental conditions. Results: Of 846 long COVID patients who visited our clinic from February 2021 to December 2023, 545 employed patients aged between 18 and 65 years were included in this study. A total of 295 patients (54. 1%) with long COVID (median age: 43 years, female: 55. 6%) experienced changes in their working status. Those patients included 220 patients (40. 4%) who took a leave of absence, 53 patients (9. 7%) who retired, and 22 patients (4%) with reduced working hours. Most of the patients (93. 2%) with changes in working conditions had mild disease severity in the acute phase of COVID-19. The majority of those patients with mild disease severity (58. 8%) were infected in the Omicron-variant phase and included 65. 3% of the female patients. The major symptoms in long COVID patients who had changes in their working situations were fatigue, insomnia, headache, and dyspnea. Scores indicating fatigue and QOL were worsened in long COVID patients who had changes in their working situations. In addition, 63. 7% of the long COVID patients with changes in their working situations had decreases in their incomes. Conclusions: Changes in the working situation of long COVID patients who were employed had a negative impact on the maintenance of their QOL.
Open Access PDF
| Concepts | Keywords |
|---|---|
| February | employment |
| Female | job retirement |
| Japanese | leave of absence |
| Outpatient | long COVID |
| omicron variant | |
| post-COVID-19 condition |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Long COVID |
| disease | IDO | quality |
| disease | MESH | COVID-19 |
| disease | MESH | insomnia |
| disease | MESH | retirement |
| disease | VO | organization |
| disease | MESH | infection |
| disease | MESH | viral infection |
| disease | MESH | cognitive impairment |
| disease | VO | Viruses |
| disease | MESH | autoimmunity |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | abnormalities |
| disease | MESH | dysosmia |
| disease | MESH | hair loss |
| disease | IDO | symptom |
| disease | VO | vaccination |
| disease | IDO | history |
| drug | DRUGBANK | Sodium lauryl sulfate |
| disease | VO | USA |
| disease | VO | protocol |
| disease | VO | age |
| disease | IDO | primary infection |
| disease | VO | population |